447 related articles for article (PubMed ID: 10891489)
1. HMG-I/Y, a new c-Myc target gene and potential oncogene.
Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic properties of the HMG-I gene family.
Wood LJ; Maher JF; Bunton TE; Resar LM
Cancer Res; 2000 Aug; 60(15):4256-61. PubMed ID: 10945639
[TBL] [Abstract][Full Text] [Related]
3. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
4. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity.
Ben-Porath I; Yanuka O; Benvenisty N
Mol Cell Biol; 1999 May; 19(5):3529-39. PubMed ID: 10207076
[TBL] [Abstract][Full Text] [Related]
5. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.
Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K
J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043
[TBL] [Abstract][Full Text] [Related]
6. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.
Reeves R; Edberg DD; Li Y
Mol Cell Biol; 2001 Jan; 21(2):575-94. PubMed ID: 11134344
[TBL] [Abstract][Full Text] [Related]
7. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
8. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
[TBL] [Abstract][Full Text] [Related]
9. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.
Peña A; Reddy CD; Wu S; Hickok NJ; Reddy EP; Yumet G; Soprano DR; Soprano KJ
J Biol Chem; 1993 Dec; 268(36):27277-85. PubMed ID: 8262968
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.
Roy B; Beamon J; Balint E; Reisman D
Mol Cell Biol; 1994 Dec; 14(12):7805-15. PubMed ID: 7969121
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
Desbarats L; Gaubatz S; Eilers M
Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
[TBL] [Abstract][Full Text] [Related]
14. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
15. HMG-I/Y in human breast cancer cell lines.
Dolde CE; Mukherjee M; Cho C; Resar LM
Breast Cancer Res Treat; 2002 Feb; 71(3):181-91. PubMed ID: 12002338
[TBL] [Abstract][Full Text] [Related]
16. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
17. The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression.
Chau KY; Munshi N; Keane-Myers A; Cheung-Chau KW; Tai AK; Manfioletti G; Dorey CK; Thanos D; Zack DJ; Ono SJ
J Neurosci; 2000 Oct; 20(19):7317-24. PubMed ID: 11007889
[TBL] [Abstract][Full Text] [Related]
18. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
19. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y).
Chin MT; Pellacani A; Wang H; Lin SS; Jain MK; Perrella MA; Lee ME
J Biol Chem; 1998 Apr; 273(16):9755-60. PubMed ID: 9545312
[TBL] [Abstract][Full Text] [Related]
20. MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc.
Niki T; Izumi S; Saëgusa Y; Taira T; Takai T; Iguchi-Ariga SM; Ariga H
Genes Cells; 2000 Feb; 5(2):127-41. PubMed ID: 10672043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
